These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19732286)

  • 21. Molecular determinants of ginkgolide binding in the glycine receptor pore.
    Hawthorne R; Cromer BA; Ng HL; Parker MW; Lynch JW
    J Neurochem; 2006 Jul; 98(2):395-407. PubMed ID: 16805834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of compound heterozygosity for GlyRalpha1 mutations in the startle disease hyperekplexia.
    Rea R; Tijssen MA; Herd C; Frants RR; Kullmann DM
    Eur J Neurosci; 2002 Jul; 16(2):186-96. PubMed ID: 12169101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors.
    Chen Z; Dillon GH; Huang R
    Neuropharmacology; 2006 Sep; 51(4):701-8. PubMed ID: 16842826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a new ligand binding domain in the alpha1 subunit of the inhibitory glycine receptor.
    Vafa B; Lewis TM; Cunningham AM; Jacques P; Lynch JW; Schofield PR
    J Neurochem; 1999 Nov; 73(5):2158-66. PubMed ID: 10537076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subunit-specific potentiation of recombinant glycine receptors by NV-31, a bilobalide-derived compound.
    Lynch JW; Chen X
    Neurosci Lett; 2008 Apr; 435(2):147-51. PubMed ID: 18329806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia.
    del Giudice EM; Coppola G; Bellini G; Cirillo G; Scuccimarra G; Pascotto A
    Eur J Hum Genet; 2001 Nov; 9(11):873-6. PubMed ID: 11781706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperekplexia mutation R271L of alpha1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3H]strychnine binding.
    Maksay G; Bíró T; Laube B; Nemes P
    Neurochem Int; 2008 Jan; 52(1-2):235-40. PubMed ID: 17655979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel hyperekplexia allele GLRA1(S267N) affects the ethanol site of the glycine receptor.
    Becker K; Breitinger HG; Humeny A; Meinck HM; Dietz B; Aksu F; Becker CM
    Eur J Hum Genet; 2008 Feb; 16(2):223-8. PubMed ID: 18043720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the Mechanism by Which Gain-of-function Mutations to the α1 Glycine Receptor Cause Hyperekplexia.
    Zhang Y; Bode A; Nguyen B; Keramidas A; Lynch JW
    J Biol Chem; 2016 Jul; 291(29):15332-41. PubMed ID: 27226610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics and functional characterization of the glycine receptor alpha2 and alpha3 subunit.
    Heindl C; Brune K; Renner B
    Neurosci Lett; 2007 Dec; 429(1):59-63. PubMed ID: 17997221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical coassembly of glycine receptor alpha1 wildtype and the hyperekplexia mutant alpha1(P250T) in HEK 293 cells: impaired channel function is not dominant in the recombinant system.
    Breitinger HG; Becker CM
    Neurosci Lett; 2002 Oct; 331(1):21-4. PubMed ID: 12359314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recessive hyperekplexia due to a new mutation (R100H) in the GLRA1 gene.
    Coto E; Armenta D; Espinosa R; Argente J; Castro MG; Alvarez V
    Mov Disord; 2005 Dec; 20(12):1626-9. PubMed ID: 16078201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat.
    Jiang P; Yang CX; Wang YT; Xu TL
    Neuroscience; 2006 Sep; 141(4):2041-50. PubMed ID: 16806717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLRB is the third major gene of effect in hyperekplexia.
    Chung SK; Bode A; Cushion TD; Thomas RH; Hunt C; Wood SE; Pickrell WO; Drew CJ; Yamashita S; Shiang R; Leiz S; Longardt AC; Raile V; Weschke B; Puri RD; Verma IC; Harvey RJ; Ratnasinghe DD; Parker M; Rittey C; Masri A; Lingappa L; Howell OW; Vanbellinghen JF; Mullins JG; Lynch JW; Rees MI
    Hum Mol Genet; 2013 Mar; 22(5):927-40. PubMed ID: 23184146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Night blindness-associated mutations in the ligand-binding, cysteine-rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking.
    Zeitz C; Forster U; Neidhardt J; Feil S; Kälin S; Leifert D; Flor PJ; Berger W
    Hum Mutat; 2007 Aug; 28(8):771-80. PubMed ID: 17405131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of the C-terminus of the human 5-HT3A receptor subunit.
    Butler AS; Lindesay SA; Dover TJ; Kennedy MD; Patchell VB; Levine BA; Hope AG; Barnes NM
    Neuropharmacology; 2009 Jan; 56(1):292-302. PubMed ID: 18786552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway.
    Shan Q; Han L; Lynch JW
    Br J Pharmacol; 2012 Apr; 165(7):2113-23. PubMed ID: 21955162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.
    Thomas RH; Chung SK; Wood SE; Cushion TD; Drew CJ; Hammond CL; Vanbellinghen JF; Mullins JG; Rees MI
    Brain; 2013 Oct; 136(Pt 10):3085-95. PubMed ID: 24030948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutation of GLRA1 in Omani families with hyperekplexia and mild mental retardation.
    Al-Futaisi AM; Al-Kindi MN; Al-Mawali AM; Koul RL; Al-Adawi S; Al-Yahyaee SA
    Pediatr Neurol; 2012 Feb; 46(2):89-93. PubMed ID: 22264702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of bestrophin-1 missense mutations associated with autosomal recessive bestrophinopathy.
    Davidson AE; Millar ID; Burgess-Mullan R; Maher GJ; Urquhart JE; Brown PD; Black GC; Manson FD
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3730-6. PubMed ID: 21330666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.